Poseida Therapeutics, Inc.

PSTX · NASDAQ
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
12/31/2023
Operating Activities
Net Income$20-$31-$24-$25
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$4
Stock-Based Comp.$5$8$5$5
Change in WC-$66$62$4-$8
Other Non-Cash$30$9$10$6
Operating Cash Flow-$10$38-$15-$29
Investing Activities
PP&E Inv.-$1-$1-$0-$0
Net Acquisitions$0$0$0$41
Inv. Purchases-$32-$103-$53-$22
Inv. Sales/Matur.$60$43$78$70
Other Inv. Act.$0-$60$24$48
Investing Cash Flow$28-$61$24$48
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued-$1$0$1-$14
Stock Repurch.$1$0-$1$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$0-$0$14
Financing Cash Flow$1$0-$0$95
Forex Effect$0$0$0-$95
Net Chg. in Cash$19-$23$9$19
Supplemental Information
Beg. Cash$31$53$44$26
End Cash$49$31$53$44
Free Cash Flow-$10$37-$15-$29